Profile
Pieter Spee is currently the Chief Scientific Officer at Pure Biologics SA since 2023.
Prior to this, he worked as the Scientific Director-Translational Immunology at Novo Nordisk A, Chief Scientific Officer at TikoMed AB, and Chief Technology Officer at FibroTx OÜ.
He obtained his doctorate degree from the University of Leiden in 1996.
Pieter Spee active positions
| Companies | Position | Start |
|---|---|---|
| PURE BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 25/05/2023 |
Former positions of Pieter Spee
| Companies | Position | End |
|---|---|---|
FibroTx OÜ | Chief Tech/Sci/R&D Officer | - |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Pieter Spee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pure Biologics SA
Pure Biologics SA BiotechnologyHealth Technology Operates as a a biopharmaceutical company which develops biological medicines, diagnostic tests and medical devices with therapeutic use | Health Technology |
FibroTx OÜ |
- Stock Market
- Insiders
- Pieter Spee
















